New strategies for the treatment of hormone-independent prostate cancer

被引:0
|
作者
DWW Newling
机构
[1] AZVU,Department of Urology
来源
Prostate Cancer and Prostatic Diseases | 2000年 / 3卷
关键词
hormone independent prostatic cancer; new strategies; therapy;
D O I
暂无
中图分类号
学科分类号
摘要
It is quite likely that in every prostate cancer, at the start of clinical disease there are hormone-independent cells present. These cells may be sensitive to changes in the diet, to chemotherapeutic agents, to immunological agents, to the use of vaccines or may be sensitive to radiotherapy. The introduction of these non-hormonal therapies has classically been reserved for the time when the patient has exhausted all other treatment therapies and has a large tumour volume which will almost certainly not respond to such treatments. The purpose of this chapter will be to try to arrive at a more sensible definition of hormone-independent disease than has been used in the past, to outline some of the new treatment strategies and to make suggestions as to where in the natural history of the disease these would be most effectively and easily employed.
引用
收藏
页码:290 / 295
页数:5
相关论文
共 50 条
  • [1] New strategies for the treatment of hormone-independent prostate cancer
    Newling, DWW
    PROSTATE CANCER AND PROSTATIC DISEASES, 2000, 3 (04) : 290 - 295
  • [2] HORMONE-INDEPENDENT CANCER OF THE PROSTATE
    GRAVES, RC
    DESAUTELS, RE
    WARREN, S
    JOURNAL OF UROLOGY, 1958, 79 (02): : 324 - 332
  • [3] Molecular aspects of hormone-independent prostate cancer
    Schalken, Jack A.
    BJU INTERNATIONAL, 2007, 100 : 52 - 55
  • [4] Secondary hormonal ablation in hormone-independent prostate cancer
    Schilling, D.
    Gakis, G.
    Boekeler, U.
    Stenzl, A.
    Kuczyk, M. A.
    Merseburger, A. S.
    UROLOGE, 2009, 48 (02): : 183 - 188
  • [5] Molecular Pathways in the Progression of Hormone-Independent and Metastatic Prostate Cancer
    Wegiel, B.
    Evans, S.
    Hellsten, R.
    Otterbein, L. E.
    Bjartell, A.
    Persson, J. L.
    CURRENT CANCER DRUG TARGETS, 2010, 10 (04) : 392 - 401
  • [6] Development of an immunotherapeutic adenovirus targeting hormone-independent prostate cancer
    Kim, Jae Sik
    Lee, Sang Don
    Lee, Sang Jin
    Chung, Moon Kee
    ONCOTARGETS AND THERAPY, 2013, 6 : 1635 - 1642
  • [7] Maspin mediates the gemcitabine sensitivity of hormone-independent prostate cancer
    Huang, Chien-Yu
    Chang, Yu-Jia
    Luo, Sheng-Dean
    Uyanga, Batzorig
    Lin, Feng-Yen
    Tai, Cheng-Jeng
    Huang, Ming-Te
    TUMOR BIOLOGY, 2016, 37 (03) : 4075 - 4082
  • [8] ANDROGEN RECEPTOR MUTATIONS IN HUMAN HORMONE-INDEPENDENT PROSTATE-CANCER
    TAPLIN, ME
    BUBLEY, G
    FRANZ, ME
    BALK, SP
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1994, : 239 - 239
  • [9] An oncolytic conditionally replicating adenovirus for hormone-dependent and hormone-independent prostate cancer
    W-S Cheng
    H Dzojic
    B Nilsson
    T H Tötterman
    M Essand
    Cancer Gene Therapy, 2006, 13 : 13 - 20
  • [10] An oncolytic conditionally replicating adenovirus for hormone-dependent and hormone-independent prostate cancer
    Cheng, WS
    Dzojic, H
    Nilsson, B
    Tötterman, TH
    Essand, M
    CANCER GENE THERAPY, 2006, 13 (01) : 13 - 20